Estrogens have been reported to induce the down regulation of TLR9 expression in Estrogen Receptor (ER)+ breast cancer cell lines [48], but nothing has been reported regarding the expression and function of TLR9 on myeloid and lymphoid cells. This evidence concerns the gene ESR1 and breast carcinoma.